Detection of circulating and endothelial cell polymers of Z and wild type α1-antitrypsin by a monoclonal antibody

被引:63
作者
Janciauskiene, S
Dominaitiene, R
Sternby, NH
Piitulainen, E
Eriksson, S
机构
[1] Malmo Univ Hosp, Dept Resp Med, S-20502 Malmo, Sweden
[2] Malmo Univ Hosp, Dept Pathol, S-20502 Malmo, Sweden
[3] Malmo Univ Hosp, Dept Internal Med, S-20502 Malmo, Sweden
关键词
D O I
10.1074/jbc.M203832200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Globular inclusions of abnormal alpha1-antitrypsin (AAT) in the endoplasmic reticulum of hepatocytes are a characteristic feature of AAT deficiency of the PiZZ phenotype. Monoclonal antibodies, which contain constant specificity and affinity, are often used for the identification of Z-mutation carriers. A mouse monoclonal antibody (ATZ11) raised against PiZZ hepatocytic AAT was successfully used in enzyme-linked immunosorbent assays (ELISA) and in identification of Z-related AAT globular inclusions by immunohistochemical techniques. Using electrophoresis, Western blotting, and ELISA procedures, we have shown in the present study that this monoclonal antibody specifically detects a conformation-dependent neoepitope on both polymerized and elastase-complexed molecular forms of AAT. The antibody has no apparent affinity for native, latent, or cleaved forms of AAT. The antibody ATZ11 illustrates the structural resemblance between the polymerized form of AAT and its complex with elastase and provides evidence that Z-homozygotes beyond the native form may have at least one more circulating molecular form of AAT, i.e. its polymerized form. In addition, staining of endothelial cells with ATZ11 antibody in both M- and Z-AAT individuals shows that AAT attached to endothelial cells is in a polymerized form. The antibody can be a powerful tool for the study of the molecular profile of AAT, not only in Z-deficiency cases but also in other (patho)physiological conditions.
引用
收藏
页码:26540 / 26546
页数:7
相关论文
共 61 条
[21]   Chronic liver disease in heterozygous α1-antitrypsin deficiency PiZ [J].
Fischer, HP ;
Ortiz-Pallardó, ME ;
Ko, Y ;
Esch, C ;
Zhou, H .
JOURNAL OF HEPATOLOGY, 2000, 33 (06) :883-892
[22]  
FORSYTH KD, 1994, CLIN EXP IMMUNOL, V95, P277
[23]   Inactive conformation of the serpin α1-antichymotrypsin indicates two-stage insertion of the reactive loop:: Implications for inhibitory function and conformational disease [J].
Gooptu, B ;
Hazes, B ;
Chang, WSW ;
Dafforn, TR ;
Carrell, RW ;
Read, RJ ;
Lomas, DA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (01) :67-72
[24]   Structure of a serpin-protease complex shows inhibition by deformation [J].
Huntington, JA ;
Read, RJ ;
Carrell, RW .
NATURE, 2000, 407 (6806) :923-926
[25]   Immunochemical and functional properties of biliary alpha-1-antitrypsin [J].
Janciauskiene, S ;
Toth, E ;
Sahlin, S ;
Eriksson, S .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1996, 56 (07) :597-608
[26]   Conformational properties of serine proteinase inhibitors (serpins) confer multiple pathophysiological roles [J].
Janciauskiene, S .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2001, 1535 (03) :221-235
[27]   THE ALPHA-1 ANTITRYPSIN GENE AND CHRONIC LUNG-DISEASE [J].
KALSHEKER, N ;
MORGAN, K .
THORAX, 1990, 45 (10) :759-764
[28]   Serpin alpha(1)proteinase inhibitor probed by intrinsic tryptophan fluorescence spectroscopy [J].
Koloczek, H ;
Banbula, A ;
Salvesen, GS ;
Potempa, J .
PROTEIN SCIENCE, 1996, 5 (11) :2226-2235
[29]   Conformational disease [J].
Kopito, RR ;
Ron, D .
NATURE CELL BIOLOGY, 2000, 2 (11) :E207-E209
[30]   Partitioning of serpin-proteinase reactions between stable inhibition and substrate cleavage is regulated by the rate of serpin reactive center loop insertion into β-sheet A [J].
Lawrence, DA ;
Olson, ST ;
Muhammad, S ;
Day, DE ;
Kvassman, JO ;
Ginsburg, D ;
Shore, JD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (08) :5839-5844